OES Vaccines Portfolio
Vaccines are one of the most important public health interventions, responsible for saving thousands of lives in the United States every year. Despite this, adult vaccination rates fall well below Healthy People 2020 targets, and the estimated economic burden of vaccine-preventable diseases among adults in the United States was about $9 billion in 2015 alone.
In partnership with the National Vaccine Program Office (NVPO), which identified low rates of adult vaccination as a national priority, OES engaged several federal agencies to build a portfolio of evidence to examine how low-cost program changes can improve vaccination rates. OES works directly with implementation entities (such as state Departments of Health and Veterans Affairs health facilities) to identify existing programs where evidence-based changes can be implemented and tested in rapid-cycle evaluations (embedded into existing operations) using random assignment.
Working with agency collaborators and delivery partners, OES has completed more than five randomized evaluations to test the impact of low-cost evidence-based program changes in improving vaccine uptake. We look forward to releasing results from these projects in late 2018.